Coapt Systems Launches SurgiWire(TM) Incisionless Dissector; First in a Series of Minimally...

PALO ALTO, Calif. -- Coapt Systems, Inc., developer of bioabsorbable implants for the fixation of soft tissue in the plastic and reconstructive surgery markets, announced today that it released the SurgiWire Incisionless Dissector for commercial sale in the U.S. market at the prestigious Baker

"This is the first in a series of minimally invasive products that we plan to introduce. This product will enable us to address the needs of patients who desire the removal of deep skin defects, such as wrinkles between the brow, the creases that run between the nose and mouth, and facial scars, with only a few needle punctures," said John Kraczkowsky, Senior Vice President, Sales and Marketing. "A considerable number of patients who would prefer cosmetic fillers to correct these defects are not ideal candidates for fillers alone due to the depth of the skin defects."

According to the American Society for Aesthetic Plastic Surgery (ASAPS), over 3 million filler procedures were performed in the U.S. in 2004. The SurgiWire(TM) device is highly desirable for patients who seek skin rejuvenation of deep lines and scars without significant downtime. According to Dr. David Apfelberg, Medical Director for Coapt Systems, "These patients previously had to resort to more invasive means to correct these problems."

Dr. Miles Graivier, a national authority on wire dissection who presented from the podium on the topic at Baker Gordon, states, "SurgiWire achieves excellent cosmetic results by separating dermal imperfections from their underlying attachments. I can use fillers such as fat or synthetic agents to supplement the results of the device, but the SurgiWire Release works so well that fillers are not always needed."

SurgiWire(TM) is now available throughout the U.S.

About Coapt Systems

Coapt Systems develops, manufactures and markets a range of bio-absorbable implants for use in soft tissue fixation based upon its patented MultiPoint Technology (MPT(TM)) platform. Coapt's product lineup includes the ENDOTINE Forehead, Midface ST, Midface B, TransBleph and Triple devices, all of which are FDA approved. The company is also developing products for hand tendon and minimally invasive face lifts. Located in Palo Alto, California, Coapt Systems, Inc. is a privately held company with 45 employees.

For further information, visit www.coaptsystems.com.